Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

House seeks to protect contraception after Roe changes - Roll Call

Eight Republicans crossed the aisle to join every House Democrat on a bill that would codify the federal right to contraception.

Roll Call

TikTok’s ‘Pink Sauce’ Is Appalling The Internet When Did We Stray So Far From The Path Of God

It's the EZ Squirt of our generation.

Pedestrian.tv

Food expiration dates don't have much science behind them – a food safety researcher explains another way to know what's too old to eat

Florida’s outbreak of listeria has so far led to at least one death, 22 hospitalizations and an ice cream recall since January. Humans get sick with listeria infections, or listeriosis, from eating soil-contaminated food, undercooked meat or dairy products that are raw, or unpasteurized. Listeria can cause convulsions, coma, miscarriage…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday

Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.

Benzinga

Clinics now allowed to purchase, prescribe antiviral drugs

The Food and Drug Administration has given the green light for clinics to purchase and prescribe molnupiravir and other antiviral drugs for Covid-19 patients.

Bangkok Post

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

Benzinga

Experts still torn on throat swabbing

Other countries' health bureaus have advised the public to throat-swab when taking at-home tests, but not the US

Salon

Read news from The Economist, FT, and more,
with one subscription

Abbott reports strong earnings despite infant formula crisis

Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to criticism over problems that led to the shutdown of one of its infant formula-producing plants.

Chicago Tribune

How canine heart disease was tied to grain-free dog food

In 2018, the FDA began investigating whether the increasing popularity of grain-free dog foods had led to a sudden rise in a potentially fatal heart disease in dogs

The Independent UK

The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get fourth COVID booster now, or wait? CDC says get the shot now, but many hesitate

About 70% of Americans 50 and older who got a first booster shot — and nearly as many of those 65 and older — haven’t gotten their second booster dose, the CDC says.

Chicago Sun-Times

Skittles "unfit" for humans: lawsuit

When Americans eat Skittles, are they tasting more than just the rainbow?

Salon

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.

Benzinga

FDA weighs oversight changes after Juul, formula troubles

The head of the Food and Drug Administration is commissioning an independent review of the agency’s food and tobacco programs

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Is Novavax a Buy, Sell, or Hold Following FDA Decision?

Despite the FDA authorization of Novavax’s (NVAX) two-dose vaccine, the possible side effects and slow vaccine uptake keep the stock under pressure. So, let’s evaluate if it is worth adding the stock to one’s portfolio now. Read on….

Benzinga

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Tribune News Service

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget COVID-19, monkeypox and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

Daily Mirror

Do Covid tests work in the heatwave – and should you put them in the fridge?

Lateral flow tests might not be as effective in the record-breaking temperatures unless users take action before using the do-it-yourself swabs

Get all your
news in one place.

100's of premium titles.
One news app.

Los Angeles Times

Skittles ‘unfit for human consumption,’ California lawsuit claims

Skittles, the colorful, fruit-flavored candy, are coming under fire after a lawsuit filed in Northern California says people are tasting more than the rainbow.

Reason

Return of Summer Security Theater? Also, Abolish the FDA.

Plus: The editors select their most influential post-war libertarian thinkers.

Tribune News Service

On Nutrition: Sorting the facts

I have a very nice patient who comes to appointments with questions about everything except his main medical problem. These are from his last visit:

The Independent UK

Candy giant Mars is sued by California man claiming Skittles contain dangerous toxin

‘Our use of titanium dioxide complies with FDA regulations,’ Mars says

Tribune News Service

When Massachusetts tried to ban an opioid, a court said no. What about abortion pills?

WASHINGTON — Efforts in states to further restrict medication abortion face legal questions over potential conflicts with federal drug regulations.

Benzinga

The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours:

StockNews.com

1 Biotech Stock That Stands out From the Rest

Amgen (AMGN) has undertaken several strategic growth initiatives to capitalize on the expanding biotech industry. In addition, several FDA drug approvals and other research and development breakthroughs make it well-positioned to witness significant growth in the near term, making it an ideal candidate for investors seeking to gain exposure in…

1 … 182 183 184 185

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Public Health Ministry

435 stories

Hill

389 stories

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.